This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

This product is a competitive angiotensin converting enzyme inhibitor, which prevents angiotensin I from being converted into angiotensin II, thereby reducing peripheral vascular resistance and reducing water and sodium retention by inhibiting aldosterone secretion. This product can also dilate peripheral blood vessels by interfering with the degradation of bradykinin. For patients with heart failure, this product can also reduce capillary wedge pressure and pulmonary vascular resistance, increase cardiac output and exercise tolerance time.

Tetracycline antibiotics are broad-spectrum antibacterial agents with bactericidal effects at high concentrations. They are sensitive to Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes; they are more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococci are resistant to them. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are also sensitive to them. They have certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae are resistant to them. Due to the widespread use of tetracyclines, common clinical pathogens are seriously resistant to them, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli.

This product is a nitrofuran antibacterial drug. It has certain antibacterial effects on both Gram-positive and Gram-negative bacteria, including Salmonella, Shigella, Escherichia coli, Klebsiella pneumoniae, Enterobacter, Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, Vibrio cholerae, Campylobacter, Bacteroides, etc. It is also active against Trichomonas and Giardia at a certain concentration. Its mechanism of action is to interfere with bacterial oxidoreductase and thus block the normal metabolism of bacteria.

This product is a nitrofuran antibacterial drug. It has certain antibacterial effects on both Gram-positive and Gram-negative bacteria, including Salmonella, Shigella, Escherichia coli, Klebsiella pneumoniae, Enterobacter, Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, Vibrio cholerae, Campylobacter, Bacteroides, etc. It is also active against Trichomonas and Giardia at a certain concentration. Its mechanism of action is to interfere with bacterial oxidoreductase and thus block the normal metabolism of bacteria.